🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label study will evaluate EMB-001, comprised of metyrapone, a cor...
Status
Unknown
Location
Rose Research Center
Start Date
2021-05-19
Trial ID
NCT04868253
Treatments Being Tested
Subjects will be randomly assigned to receive either one of the two potenti...
Status
Completed
Location
Department of Psychiatry, Psychopharmacology Research Clinic
Start Date
2007-12
Trial ID
NCT00567814
Treatments Being Tested
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyra...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2018-03-01
Trial ID
NCT03404817
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Pacific Treatment and Research Center, Department of Psychiatry, University of California, San Diego, School of Medicine
Start Date
2020-07-29
Trial ID
NCT04501874
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Terminated
Location
Embera Site
Start Date
2021-06-10
Trial ID
NCT04933916
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Vince & Associates
Start Date
2016-07
Trial ID
NCT02856854
Treatments Being Tested
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyra...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2015-03
Trial ID
NCT02406066
Treatments Being Tested